PharmaShots | Incisive News in 3 Shots

Subscribe Now

Primary Hyperoxaluria

Dicerna Reports Results of Nedosiran in PHYOX4 Study for the Treatment of Primary Hyperoxaluria Type 3

Dicerna Reports Results of Nedosiran in PHYOX4 Study for the Treatment of Primary Hyperoxaluria Type 3

October 20, 2021

Dicerna Presents New Interim Data of PHYOX 3 OLE Study Evaluating Nedosiran for Primary Hyperoxaluria at ASN Week 2020

Dicerna Presents New Interim Data of PHYOX 3 OLE Study Evaluating Nedosiran for Primary Hyperoxaluria at ASN Week 2020

October 23, 2020

OxThera's Oxabact Receives EMA's Positive Decision on Pediatric Investigational Plan to Treat Primary Hyperoxaluria

OxThera's Oxabact Receives EMA's Positive Decision on Pediatric Investigational Plan to Treat Primary Hyperoxaluria

August 23, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us